MODEL 50 BIPOLAR COAGULATOR

K972350 · Boston Surgical Products, Inc. · GEI · Aug 21, 1997 · General, Plastic Surgery

Device Facts

• Record ID: K972350
• Device Name: MODEL 50 BIPOLAR COAGULATOR
• Applicant: Boston Surgical Products, Inc.
• Product Code: GEI · General, Plastic Surgery
• Decision Date: Aug 21, 1997
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4400
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Boston Surgical Products, Inc. Model 50 Coagulator General purposes solid state bipolar generator to supply the RF signal to clectrosurycal handpieces used to coagulate soft body tissues where a wide range of tissue types, patient conditions, and load impediances are encountered.

Device Story

Model 50 Bipolar Coagulator Generator; solid-state RF generator; supplies RF signal to electrosurgical handpieces for soft tissue coagulation. Features 0-50 digital power display (+/- 5 watts at 100 ohms); bar graph output current monitor; independent 7 Vdc isolated power supply for handswitch. Used in clinical settings by physicians. Provides visual/audio feedback on energy delivery. Ensures RF/low-frequency leakage compliance with IEC 601-1-2 and ANSI HF-18 standards for isolated bipolar coagulators.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Solid-state RF generator; 0-50 digital power display; bar graph current monitor; 7 Vdc isolated handswitch power supply. Complies with IEC 601-1-2 and ANSI HF-18 for isolated (body floating) bipolar coagulators.

Indications for Use

Indicated for coagulation of soft body tissues in patients requiring electrosurgical procedures across a wide range of tissue types, conditions, and load impedances.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Submission Summary (Full Text)

{0}------------------------------------------------

U.S. Food and Drug Administration 510K Document Mail Center HFZ-401 Center for Medical Devices 1390 Piccard Drive Rockville, Maryland 20850

## <972350

AUG 21 1997

l

To: Document Control Clerk

This summary of 510K safety and effectiveness for the Model 50 Coagulation Generator is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807,92.

A 0-50 digital display power setting indicator provides the operator a parallax free reading of the power setting (+/- Swatts, full scale (@ 100 ohms).

A bar graph display output current monitor provides the operator a relative measure of the output current amplitude and to denote the presence of output energy during activation.

The handswitch is powered by an independent low voltage (7 Vdc) isolated power supply.

Audio and Visual monitors are in accord with IEC 601-1-2 and ANSI HF-18 guidelines.

RF and Low Frequency leakages are well within IEC 601-1-2 and ANSI HF-18 safety guide lines for isolated (body floating) bipolar coagulators.

This device is identical to an existing approved device.

Sincerely,

Charles Vursello

Date

12 JUN 97

Charles Vassallo Boston Surgical Products, Inc. 17 Old Country Road Oxford, Connecticutt 06478 Telephone/FAX [phone]

3

{1}------------------------------------------------

Image /page/1/Picture/2 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. In the center of the seal is a stylized image of an eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Charles Vassallo Boston SurgicalProducts, Inc. 17 Old Country Road Oxford, Connecticut 06478

AUG 21 1991

Re: K972350 Trade Name: Model 50 Bipolar Coagulator Regulatory Class: II Product Code: GEI Dated:June 12, 1997 Received: June 24, 1997

Dear Mr. Vassallo:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{2}------------------------------------------------

Page 2 - Mr. Charles Vassallo

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Sincerely yours,

[signature]

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Page 1 of 1

S10K Number (if known):

K972350

Device Name: Model 50 Bipolar Coaguiator Generator

Indications for Use: -- -

The Boston Surgical Products, Inc. Model 50 Coagulator General purposes solid state bipolar generator to supply the RF signal to clectrosurycal handpieces used to coagulate soft body tissues where a wide range of tissue types, patient conditions, and load impediances are encountered.

## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| (Division Sign-Off) | |
|-----------------------------------------|----------|
| Division of General Restorative Devices | |
| 510(k) Number | k9722350 |

| Prescription Use<br>Per 21 CFR 801 109) | OR | Over The Counter Use:<br>(Optional Format 1-2-96) |
|-----------------------------------------|----|---------------------------------------------------|
|-----------------------------------------|----|---------------------------------------------------|